Insider Holders & Insider Ownership - GYRE THERAPEUTICS INC. (GYRE)

List of insiders holdings for GYRE THERAPEUTICS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time		 Shares Owned
Directly
Indirectly		 Total
Shares Owned		 Filing
1 GNI Group Ltd.
GNI USA Inc.
10% Owner		 2024-01-24 17:11:14 73,313,885
0		 73,313,885 Form 13D
2 Luo Ying
Director		 2024-09-06 08:15:45 8,458,983
0		 8,458,983 Form 13D
3 PERRY MARK W
10% Owner		 2008-01-18 19:09:46 0
5,865,512		 5,865,512 Form 4
4 NEWHALL CHARLES W III
10% Owner		 2008-01-18 19:10:00 0
5,865,512		 5,865,512 Form 4
5 TRAINOR III EUGENE A
10% Owner		 2008-01-18 19:11:23 0
5,863,512		 5,863,512 Form 4
6 NEA PARTNERS 10 L P
10% Owner		 2008-01-18 19:12:24 0
5,863,512		 5,863,512 Form 4
7 GNI Hong Kong Ltd
10% Owner		 2023-10-27 19:56:00 5,371,304
0		 5,371,304 Form 4
8 KRAMLICH C RICHARD
10% Owner		 2012-11-20 15:50:33 0
4,568,845		 4,568,845 Form 4
9 BARRETT M JAMES
10% Owner		 2013-12-05 15:07:55 0
4,563,512		 4,563,512 Form 4
10 SANDELL SCOTT D
10% Owner		 2013-12-05 15:15:07 0
4,563,512		 4,563,512 Form 4
11 BARRIS PETER J
10% Owner		 2013-12-05 15:15:46 0
4,563,512		 4,563,512 Form 4
12 MORRIS PETER
10% Owner		 2007-02-08 18:07:21 0
3,265,512		 3,265,512 Form 4
13 Ma Songjiang
President		 2025-03-25 16:01:33 0
2,824,844		 2,824,844 Form 4
14 Himawan Jeff
Director
10% Owner		 2015-08-20 18:10:32 0
2,405,871		 2,405,871 Form 4
15 Essex Woodlands Health Ventures VIII L.L.C.
Essex Woodlands Health Ventures VIII L.P.
10% Owner		 2015-08-31 15:30:59 1,226,519
0		 1,226,519 Form 13D
16 JFL Capital Management LLC
5% owner		 2019-02-11 13:38:24 839,070
0		 839,070 Form 13G
17 HANHAM ANN
Director		 2006-04-18 15:48:48 0
779,062		 779,062 Form 4
18 EuclidSR Partners L.P.
EuclidSR Associates L.P.
10% Owner		 2010-02-02 17:58:51 556,631
0		 556,631 Form 13G
19 NOMURA INTERNATIONAL PLC
Nomura Phase4 Ventures GP LTD
Nomura Phase4 Ventures LP
Nomura Phase4 Ventures LTD
10% Owner		 2010-02-12 14:29:20 519,716
0		 519,716 Form 13G
20 EuclidSR Biotechnology Associates L.P.
EuclidSR Biotechnology Partners L.P.
10% Owner		 2006-04-18 17:59:57 371,748
0		 371,748 Form 4
21 Ying Han
Chief Executive Officer		 2024-08-16 20:50:24 341,000
0		 341,000 Form 4
22 Eastling Thomas Wilson
Director		 2025-04-18 17:27:15 314,652
0		 314,652 Form 4
23 Ye Weiguo
Chief Operating Officer		 2025-03-11 20:00:30 300,000
0		 300,000 Form 4
24 USMAN NASSIM
Director		 2024-07-01 18:00:33 279,836
640		 280,476 Form 4
25 Wu Charles C
Chief Executive Officer		 2023-11-22 19:20:00 170,417
0		 170,417 Form 4
26 deBethizy J Donald
President and CEO		 2012-05-08 17:51:31 135,000
0		 135,000 Form 4
27 Zorn Peter A
SVP, Lgl Affrs, GC & Secretary		 2013-01-18 17:26:31 65,000
0		 65,000 Form 4
28 Brennan Jeffrey P
SVP, Bus. and Comm. Dev. & CBO		 2013-01-18 17:16:12 65,000
0		 65,000 Form 4
29 Madison Edwin
Chief Scientific Officer		 2015-12-15 17:37:53 58,572
0		 58,572 Form 4/A
30 Musso Alan A
SVP, Fin+Admin, CFO & Treas		 2014-10-21 16:22:28 57,799
0		 57,799 Form 4
31 Dunbar Geoffrey C
SVP, Clin. Dev. & Reg. Affairs		 2011-03-31 19:10:31 55,500
0		 55,500 Form 4
32 Musil Clinton
Chief Financial Officer		 2021-04-26 17:38:43 54,000
0		 54,000 Form 4/A
33 Zhang Ping
Director		 2025-01-07 16:05:41 52,000
0		 52,000 Form 4
34 Nussbaum Rodney L
Director		 2024-08-16 21:13:29 52,000
0		 52,000 Form 4
35 Parry Renate
Director		 2024-08-16 21:10:28 52,000
0		 52,000 Form 4
36 Epstein David M.
Director		 2024-08-16 21:07:51 52,000
0		 52,000 Form 4
37 Carmichael Gordon
Director		 2024-08-16 21:05:18 52,000
0		 52,000 Form 4
38 Chen Ruoyu
Chief Financial Officer		 2024-08-16 20:53:18 50,000
0		 50,000 Form 4
39 Rock Patrick C.
Secretary, GC		 2015-08-18 15:38:44 48,553
0		 48,553 Form 4
40 Toler Steven M.
VP, Clin Pharm Sciences		 2014-10-21 16:21:16 46,000
0		 46,000 Form 4
41 Hosford David A.
VP, Clin Dev & Reg Affairs		 2014-01-24 17:01:42 45,000
0		 45,000 Form 4
42 Hodges Mauri K
Treasurer, CFO		 2015-08-18 15:34:17 44,516
0		 44,516 Form 4
43 Hicks Karen A
VP, Human Resources		 2013-01-18 17:17:46 40,000
0		 40,000 Form 4
44 Bencherif Merouane
SVP and Senior Scien Fellow		 2013-01-18 17:14:41 40,000
0		 40,000 Form 4
45 Williams Eddie
Director		 2022-01-07 17:33:42 34,804
0		 34,804 Form 4
46 Ling Geoffrey M.D.
Director		 2022-01-07 17:31:57 31,790
0		 31,790 Form 4
47 DESOUZA ERROL B
Director		 2021-10-05 16:32:07 29,801
0		 29,801 Form 4
48 JEW JEANNE Y
Director		 2021-09-13 20:13:11 28,000
0		 28,000 Form 4
49 Jones Elaine V
Former Director as of 6/13/07
Director		 2008-02-25 16:39:55 27,500
0		 27,500 Form 4/A
50 Levy Howard
Chief Medical Officer		 2021-08-11 09:14:29 639
23,390		 24,029 Form 4
51 SKALETSKY MARK B
Director		 2013-06-10 15:23:12 17,500
0		 17,500 Form 4
52 BROWN JULIA R
Director		 2015-08-18 15:39:02 17,263
0		 17,263 Form 4
53 TETLOW SHARON
Director		 2021-07-02 09:55:42 14,000
0		 14,000 Form 4
54 SELICK HAROLD E
Director		 2018-01-18 18:03:05 11,697
0		 11,697 Form 4
55 DUNTON ALAN W
Director		 2015-08-18 15:34:08 10,789
0		 10,789 Form 4
56 BLIXT CHARLES A
Director		 2015-08-18 15:35:38 10,789
0		 10,789 Form 4
57 Blouse Grant E.
Chief Scientific Officer		 2022-08-10 17:17:57 9,417
0		 9,417 Form 4
58 Caldwell William S
SVP - Drug Discovery and Dev.		 2011-09-29 14:42:32 6,735
2,500		 9,235 Form 4
59 SNYDERMAN RALPH
Director		 2012-06-08 17:15:46 7,500
0		 7,500 Form 4
60 Cai Veronica
Controller		 2020-03-13 18:55:34 7,353
0		 7,353 Form 4
61 BURRILL STEVEN
Director		 2012-08-01 17:22:32 0
4,333		 4,333 Form 4
62 Richard John P
Director		 2020-03-13 18:56:17 3,716
0		 3,716 Form 4
63 HILL STEPHEN A
Director		 2018-09-06 21:41:02 1,190
0		 1,190 Form 4
64 LAWLOR AUGUSTINE
Director		 2023-09-01 16:07:04 0
0		 0 Form 4
65 Flynn James E
Deerfield Mgmt L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Special Situations Fund L.P.
DEERFIELD PARTNERS L.P.
Possible Member of 10% Group
10% Owner		 2019-02-12 16:11:58 0
0		 0 Form 13G
66 Payne Fletcher
Chief Financial Officer		 2019-09-25 14:03:29 0
0		 0 Form 4
67 NEW ENTERPRISE ASSOCIATES 10 L P
10% Owner		 2017-05-23 17:20:54 0
0		 0 Form 13D
68 BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND II LP
BVF INC
LAMPERT MARK N
BVF INVESTMENTS LLC
INVESTMENT 10 LLC
See Explanation of Responses		 2017-02-14 12:53:49 0
0		 0 Form 13G
69 Hunt Andrea
Director		 2023-09-01 16:07:08 0
0		 0 Form 4
70 Miller Seline E.
SVP Finance; Interim CFO & PAO		 2023-09-01 16:07:11 0
0		 0 Form 4